US-approved drug to improve quality of life for people with rare condition familial chylomicronemia syndrome

For the first time, a drug to treat adult patients with familial chylomicronemia syndrome (FCS), a severe and rare condition that leads to extremely high levels of blood fats called triglycerides, has been approved by the U.S. Food and Drug…

Continue Reading

News Source: medicalxpress.com